No (healthy adults or slightly overweight subjects)
Conditions
Interventions
Ingestion of 4 tablets containing lactoferrin and cacao extract once a day for 12 weeks
Ingestion of 4 tablets not containing lactoferrin and cacao extract once a day for 12 weeks
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Males and females aged 20 to 64 years old. (2) Subjects have three square meals a day. (3) Subjects whose BMI are 23 to 24.9 or 25 to 29.9. (4) Subjects with visceral fat areas of more than 80 cm2 (on CT analysis) at the screening test. (5) Subjects giving written informed consent.
Exclusion criteria
Exclusion criteria: (1) Subjects who use medications affecting obesity, hyperlipidemia, lipid metabolism, and so on. (2) Subjects who can't stop using supplements and/or functional foods affecting obesity, hyperlipidemia, lipid metabolism, and so on. (3) Subjects who are pregnant or lactating. (4) Subjects who have under treatment or a history of drug addiction and/or alcoholism. (5) Subjects who are planned to participate in other clinical study. (6) Subjects who are judged as unsuitable for the study by the investigator for the other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Visceral fat area 2) Total fat area 3) Subcutaneous fat area measured before and 12 weeks after ingestion of the tablets. | — |
Countries
Japan
Contacts
Public ContactYoshika Komori
KSO Corporation Sales department
Outcome results
None listed